DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Beyer-Westendorf J, Gelbricht V, Forster K. et al.
Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.
Br J Clin Pharmacol 2014;
78: 908-917.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.